Search results
Janet Woodcock (born August 29, 1948) is an American physician serving as Principal Deputy Commissioner of Food and Drugs, having previously served as Acting Commissioner of the U.S. Food and Drug Administration (FDA).
- Roger Miller
- Robert Califf
Feb 17, 2022 · Janet Woodcock is the FDA’s Principal Deputy Commissioner. In this role she works closely with the Commissioner of Food and Drugs to develop and implement key public health initiatives and...
- Principal Deputy Commissioner
- Office of The Commissioner
Nov 16, 2023 · WASHINGTON, Nov 16 (Reuters) - U.S. Food and Drug Administration (FDA) Principal Deputy Commissioner Dr. Janet Woodcock, who led the regulator during the height of the COVID-19 pandemic as...
Nov 17, 2023 · WOODCOCK SET TO RETIRE — Longtime FDA regulator Janet Woodcock, who has worked at the agency since 1986, plans to retire in early 2024, FDA Commissioner Robert Califf told agency staff...
Nov 16, 2023 · Bloomberg News. US Food and Drug Administration Deputy Commissioner Janet Woodcock will retire next year after nearly four decades at the regulator that were marked by controversy over support for unproven medications for rare, serious conditions. Woodcock confirmed the news in an email.
Nov 16, 2023 · W ASHINGTON — Principal Deputy FDA Commissioner Janet Woodcock will retire early next year from the Food and Drug Administration after helping steer the agency through an historic period of...
Jan 30, 2024 · Janet Woodcock, the FDA's principal deputy commissioner Chip Somodevilla/Getty Images. W ASHINGTON — It’s the end of an era for the Food and Drug Administration’s longtime drug chief, but she’s...
